Comprehensive Analysis
Over the past five years, ISU Chemical's performance has been a story of one strong year followed by a sharp and sustained downturn. When comparing the five-year trend (FY2020-FY2024) to the more recent three-year period (FY2022-FY2024), a clear deceleration is evident. The average annual revenue growth over five years was approximately 6%, boosted by strong growth in FY2021 and FY2022. However, over the last three years, the trend turned negative as revenue first stalled and then declined by -3.97% in the latest fiscal year. This indicates that the earlier growth momentum was not sustainable.
A more concerning trend is visible in profitability and cash generation. The company's operating margin was positive in only one of the last five years (4.28% in FY2021). In the other four years, it was negative, averaging around -3.2%. The three-year average is also firmly negative, showing no signs of recovery. Similarly, free cash flow has collapsed. After being positive in FY2020 and FY2021, it turned sharply negative, with the company burning a cumulative total of over 280 billion KRW from FY2022 to FY2024. This shift from cash generation to significant cash burn highlights a fundamental deterioration in the business's operational health.
An analysis of the income statement reveals extreme instability. Revenue peaked at 2.0 trillion KRW in FY2022 before falling to 1.92 trillion KRW by FY2024, highlighting its cyclical nature and sensitivity to market conditions. Profitability has been even more erratic. The company was only profitable at the operating level in FY2021, reporting an operating income of 72.8 billion KRW. In the other four years combined, it accumulated operating losses exceeding 177 billion KRW. This weakness flows down the income statement, with net losses recorded in FY2020, FY2023, and FY2024. Gross margins, a key indicator of pricing power in the chemical industry, have also compressed significantly, falling from 10.61% in FY2021 to just 3.09% in FY2024, suggesting the company is struggling to pass on costs or maintain pricing in a weaker market.
The balance sheet reflects growing financial risk. While total debt remained relatively stable, hovering around 470 billion KRW, shareholder equity has been severely eroded by persistent losses. Equity fell from a peak of 405.5 billion KRW in FY2022 to 221.7 billion KRW in FY2024. This dangerous combination caused the debt-to-equity ratio to nearly double from a manageable 1.12 in FY2022 to a high-risk 2.14 in FY2024. Furthermore, liquidity has become strained. The company's working capital turned negative (-102.8 billion KRW in FY2024), and its current ratio fell below 1.0 to 0.83, signaling that short-term liabilities now exceed short-term assets, which can be a precursor to liquidity challenges.
The cash flow statement confirms the operational distress. Operating cash flow, the cash generated from core business activities, has been negative for the last three fiscal years, indicating the company is not generating enough cash to cover its day-to-day operations. The situation is worse for free cash flow (FCF), which also accounts for capital expenditures. FCF has been deeply negative for three straight years, with cash burn reaching -109.9 billion KRW in FY2023 and -98.2 billion KRW in FY2024. This sustained cash burn is unsustainable and suggests the company is reliant on external financing or cash reserves to fund its operations and investments.
Regarding capital actions, the company has a history of significant shareholder dilution. From FY2020 to FY2023, the number of shares outstanding increased substantially from 14 million to 24 million. This means existing shareholders' ownership was significantly diluted. The company also continued to pay dividends through this period. For instance, in FY2022 it paid out 20.1 billion KRW and in FY2023 it paid 14.8 billion KRW, according to the cash flow statement. While a share count reduction was noted in FY2024, the overall five-year trend is one of major dilution.
From a shareholder's perspective, the company's capital allocation strategy appears questionable. The substantial increase in share count was not matched by a sustained improvement in per-share earnings; in fact, EPS was negative for four of the five years. This suggests the capital raised through issuing shares was not deployed effectively to create lasting value. Furthermore, the decision to pay dividends while the company was burning through large amounts of cash is a significant red flag. In FY2022, for example, dividends of 20.1 billion KRW were paid while free cash flow was negative 74.2 billion KRW. This practice, funding shareholder returns with debt or existing cash rather than operational profits, is not sustainable and ultimately weakens the company's financial position.
In conclusion, the historical record for ISU Chemical does not inspire confidence. The performance has been highly erratic, marked by a single year of strong profitability surrounded by years of significant losses, cash burn, and a weakening balance sheet. The company's primary historical strength was its ability to capitalize on favorable market conditions in FY2021. However, its most significant weakness is its lack of resilience, as evidenced by its inability to maintain profitability or generate cash through the cycle. The combination of operational struggles, rising leverage, and shareholder-unfriendly capital allocation paints a picture of a high-risk company with a poor track record.